Genetic studies have identified structural mutations in pancreatic cancers; the alterations include the activation of K-Ras proto-oncogene as well as inactivation of tumor suppressor genes such as TP53 or INK4a locus [47–49]. The gene discussed is CDKN2A; the disease is pancreatic neoplasm.